Can Lilly Stock Reach $1800 by 2030? Bulls See Path
Eli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...
Choosing between price and cap weighting depends on your objectives and risk tolerance. This guide highlights strengths and trade-offs.
26,659 articlesEli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...
Qualcomm and Arm tumble as the mobile-chip complex sinks on a broader market pullback, underscoring renewed risk-off ...
A stock that utterly failed decade may finally turn the corner. This guide breaks down three tangible reasons for a p...
Nebius shares fell about 13% in afternoon trading as the neocloud trade shows renewed pressure on asset-light AI clou...
Markets brace for spillovers as tensions with Iran rise. This report examines how 'military action iran broader' coul...
President Trump touts a plan for a government-backed insurance agency to cover Gulf shipping against political risk. ...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
Bloom Energy posted a robust Q1 2026 and raised guidance, fueling a sharp stock surge. Yet traders and analysts quest...
Regulators warn of a loophole that allows new chemicals to enter foods and supplements without premarket approval. Th...
Palantir shares slip in a broad software selloff, brushing near key support as investors weigh growth prospects again...
Three AI-powered models weigh two extreme BTC futures for 2026: a downturn to $30,000 or a rally to $100,000. The art...
A fresh energy shock amid tariff tensions is tightening corporate margins. Markets moved lower as oil surged and poli...